4TEEN4 PHARMACEUTICALS GMBH : DPP3 biomarker to advance prediction of organ function progression in septic patients
MarketScreener,
DGAP-News: 4TEEN4 Pharmaceuticals GmbH / Key word(s): Research Update/Study results DPP3 biomarker to advance prediction of…
DPP3 biomarker to advance prediction of organ function progression in septic patients
Ariva,
DGAP-News: 4TEEN4 Pharmaceuticals GmbH / Key word(s): Research Update/Study results 15.04.2021 / 10:00 The issuer is solely…
4TEEN4 Pharmaceuticals GmbH: DPP3 predicts organ failure and in-hospital mortality in post-operative patients
Ariva,
DGAP-News: 4TEEN4 Pharmaceuticals GmbH / Key word(s): Study/Study results 25.03.2021 / 10:00 The issuer is solely responsible…